GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.770
-0.180 (-3.64%)
Jan 31, 2025, 4:00 PM EST - Market closed
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $1.84 billion as of January 31, 2025. Its market cap has decreased by -28.60% in one year.
Market Cap
1.84B
Enterprise Value
1.96B
1-Year Change
-28.60%
Ranking
Category
Stock Price
$4.77
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $1.84B, a decrease of -85.52%. That is a compound annual growth rate of -35.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 1.84B | 2.58% |
| Dec 31, 2024 | 1.79B | -34.24% |
| Dec 29, 2023 | 2.72B | 47.38% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.43% |
| Dec 31, 2020 | 15.79B | 24.57% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.32B |
| UnitedHealth Group | 499.25B |
| Novo Nordisk | 375.61B |
| Johnson & Johnson | 366.32B |
| AbbVie | 324.98B |
| Merck & Co. | 249.98B |
| Thermo Fisher Scientific | 228.64B |
| Abbott Laboratories | 221.89B |